4164

SA:NAHDI

Nahdi Medical Company

Stock

Last Close

118.60

24/11 08:54

Market Cap

17.26B

Beta: -

Volume Today

43.84K

Avg: -

Overview Analysis Metrics Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	692.00M -	849.12M 22.70%	857.27M 0.96%	937.93M 9.41%	944.25M 0.67%
depreciation and amortization	495.33M -	518.13M 4.60%	571.50M 10.30%	596.64M 4.40%	618.08M 3.59%
deferred income tax
stock based compensation
change in working capital	-31.19M -	-37.80M 21.17%	-13.40M 64.54%	52.49M 491.67%	-155.03M 395.35%
accounts receivables	-58.23M -	58.64M 200.71%	-47.65M 181.26%	6.89M 114.46%
inventory	-33.13M -	-189.43M 471.76%	85.85M 145.32%	-127.01M 247.95%	-214.62M 68.98%
accounts payables	84.47M -	-70.25M 183.16%	43.74M 162.26%	153.17M 250.20%
other working capital	-24.31M -	163.23M 771.54%	-95.34M 158.41%	19.44M 120.39%	59.59M 206.51%
other non cash items	191.93M -	256.40M 33.59%	-81.39M 131.74%	80.81M 199.28%	-38.57M 147.73%
net cash provided by operating activities	1.35B -	1.59B 17.64%	1.33B 15.88%	1.67B 25.03%	1.37B 17.94%
investments in property plant and equipment	-234.42M -	-319.80M 36.42%	-306.47M 4.17%	-275.23M 10.19%	-384.51M 39.70%
acquisitions net	6.18M -	13.82M 123.52%	7.10M 48.62%	103.29K 98.55%
purchases of investments	-2.47M -
sales maturities of investments		202.83M -
other investing activites					-30.39M -
net cash used for investing activites	-230.71M -	-103.15M 55.29%	-299.36M 190.23%	-275.13M 8.10%	-384.26M 39.66%
debt repayment
common stock issued
common stock repurchased
dividends paid	-500M -	-535M 7.00%	-1.26B 135.51%	-300.30M 76.17%	-715M 138.10%
other financing activites	-415.08M -	-311.53M 24.95%	-382.07M 22.64%	-416.96M 9.13%	-435.67M 4.49%
net cash used provided by financing activities	-915.08M -	-846.53M 7.49%	-1.64B 93.98%	-717.26M 56.32%	-1.15B 60.43%
effect of forex changes on cash			-23.52K -	-210.17K 793.53%	-447.82K 113.08%
net change in cash	202.28M -	636.18M 214.50%	-607.49M 195.49%	675.27M 211.16%	-166.65M 124.68%
cash at beginning of period	170.07M -	372.35M 118.94%	1.01B 170.85%	401.04M 60.23%	1.08B 168.38%
cash at end of period	372.35M -	1.01B 170.85%	401.04M 60.23%	1.08B 168.38%	909.66M 15.48%
operating cash flow	1.35B -	1.59B 17.64%	1.33B 15.88%	1.67B 25.03%	1.37B 17.94%
capital expenditure	-234.42M -	-319.80M 36.42%	-306.47M 4.17%	-275.23M 10.19%	-384.51M 39.70%
free cash flow	1.11B -	1.27B 13.68%	1.03B 18.84%	1.39B 35.54%	984.22M 29.33%

All numbers in (except ratios and percentages)